Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: J Am Acad Dermatol. 2019 Oct 22;83(3):762–772. doi: 10.1016/j.jaad.2019.10.034

Table 1.

Selected patient and transplant characteristics of melanoma cases and matched controls, Center for International Blood and Marrow Transplant Research program, 1985–2012.

Characteristic Melanoma cases (n=140) Matched controls (n=557)
n % n %
Age at transplant,* years
   <40 54 38.6 214 38.4
   40-<55 48 34.3 190 34.1
   ≥55 38 27.1 153 27.5
Sex*
   Male 79 56.4 316 56.7
   Female 61 43.6 241 43.3
Indication for transplant*
   ALL 25 17.9 100 18.0
   AML 25 17.9 100 18.0
   MDS 13 9.3 52 9.3
   Other acute leukemia 1 0.7 4 0.7
   CML 34 24.3 136 24.4
   CMML 2 1.4 8 1.4
   MPN 9 6.4 36 6.5
   CLL 12 8.6 48 8.6
   NHL 17 12.1 65 11.7
   HL 1 0.7 4 0.7
   MM 1 0.7 4 0.7
Region**
   United States 118 84.3 430 77.2
   Canada 15 10.7 88 15.8
   Europe 3 2.1 20 3.6
   Australia/New Zealand 4 2.9 19 3.4
Ambient UVR**
   Tertile 1 42 30.0 197 35.4
   Tertile 2 41 29.3 185 33.2
   Tertile 3 57 40.7 175 31.4
Karnofsky score prior to preparative regimen
   ≥90 108 77.1 410 73.6
   <90 29 20.7 114 20.5
   Missing 3 2.1 33 5.9
Transplant year
   1985–1998 37 26.4 203 36.4
   1999–2005 57 40.7 173 31.1
   2006–2012 46 32.9 181 32.5
Donor age, median (range), years 36 (5–70) 36 (<1–73)
Time from transplant to melanoma/study inclusion,* median (range), years 4 (<1–24) 4(<1–24)

Abbreviations: ALL - acute lymphocytic leukemia; AML - acute myeloid leukemia; CLL - chronic lymphocytic leukemia; CML - chronic myeloid leukemia; CMML - chronic myelomonocytic leukemia; HL - Hodgkin lymphoma; MDS - myeloproliferative disorder; MM - multiple myeloma; MPN - myeloproliferative neoplasm; mW/m2 - milliWatt per square meter; NHL - non-Hodgkin lymphoma; UVR - ultraviolet radiation.

*

Four controls were matched to each case by age (± 3 years), sex, first primary disease, and survival time without developing melanoma at least as long as the matched case’s interval from transplant to melanoma.

**

Ambient UVR was based on the region of patient residence, measured as radiation intensity (mW/m2) and divided into tertiles. If zip code was not available, nearest transplant center was used. Tertile 1: <23.0 mW/m2; Tertile 2: 23.0-<31.6 mW/m2; Tertile 3: ≥31.6mW/m2.